FR2392669A1 - Compositions antihypertensives de clonidine et de phenoxybenzamine - Google Patents
Compositions antihypertensives de clonidine et de phenoxybenzamineInfo
- Publication number
- FR2392669A1 FR2392669A1 FR7816125A FR7816125A FR2392669A1 FR 2392669 A1 FR2392669 A1 FR 2392669A1 FR 7816125 A FR7816125 A FR 7816125A FR 7816125 A FR7816125 A FR 7816125A FR 2392669 A1 FR2392669 A1 FR 2392669A1
- Authority
- FR
- France
- Prior art keywords
- phenoxybenzamine
- clonidine
- compositions
- antihypertensive compositions
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Les compositions de l'invention renferment de la N-(dichloro-2,6 phényl) dihydro-4,5 1H-imidazolamine-2 et de la N-(chloro-2 éthyl) N-méthyl-1 phénoxy-2 éthyl)benzéneméthanamine ou leurs sels non toxiques convenant en pharmacie. Les compositions de l'invention sont utiles pour le traitement de l'hypertension des mammifères et en particulier de l'homme.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/802,027 US4215130A (en) | 1977-05-31 | 1977-05-31 | Antihypertensive compositions of N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine and N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2392669A1 true FR2392669A1 (fr) | 1978-12-29 |
FR2392669B1 FR2392669B1 (fr) | 1980-04-11 |
Family
ID=25182653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7816125A Granted FR2392669A1 (fr) | 1977-05-31 | 1978-05-30 | Compositions antihypertensives de clonidine et de phenoxybenzamine |
Country Status (14)
Country | Link |
---|---|
US (1) | US4215130A (fr) |
AU (1) | AU515368B2 (fr) |
BE (1) | BE867489A (fr) |
CA (1) | CA1110170A (fr) |
DE (1) | DE2823267A1 (fr) |
FR (1) | FR2392669A1 (fr) |
GB (1) | GB1573595A (fr) |
IE (1) | IE46709B1 (fr) |
IL (1) | IL54505A0 (fr) |
NL (1) | NL189649C (fr) |
NZ (1) | NZ186893A (fr) |
PH (1) | PH13566A (fr) |
SE (1) | SE434119B (fr) |
ZA (1) | ZA781920B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603141A (en) * | 1984-11-30 | 1986-07-29 | Giles Thomas D | Oral clonidine treatment of congestive heart failure |
WO1988005789A1 (fr) * | 1987-01-29 | 1988-08-11 | Biotechnology Australia Pty. Ltd. | Isolement a partir de fluide folliculaire de proteines a chaine unique avec activite de suppression de la fsh |
US5369095A (en) * | 1990-02-14 | 1994-11-29 | Alcon Laboratories, Inc. | Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2599000A (en) * | 1950-09-02 | 1952-06-03 | Smith Kline French Lab | Nu, nu-disubstituted-beta-halo-alkylamines |
US3236857A (en) * | 1961-10-09 | 1966-02-22 | Boehringer Sohn Ingelheim | 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products |
US4022893A (en) * | 1975-01-24 | 1977-05-10 | Moyer John H | Treatment for hypertension |
-
1977
- 1977-05-31 US US05/802,027 patent/US4215130A/en not_active Expired - Lifetime
-
1978
- 1978-04-04 ZA ZA00781920A patent/ZA781920B/xx unknown
- 1978-04-05 IE IE669/78A patent/IE46709B1/en not_active IP Right Cessation
- 1978-04-05 NZ NZ186893A patent/NZ186893A/xx unknown
- 1978-04-07 AU AU34877/78A patent/AU515368B2/en not_active Expired
- 1978-04-13 IL IL54505A patent/IL54505A0/xx not_active IP Right Cessation
- 1978-04-14 PH PH21007A patent/PH13566A/en unknown
- 1978-04-27 NL NLAANVRAGE7804523,A patent/NL189649C/xx not_active IP Right Cessation
- 1978-05-05 CA CA302,706A patent/CA1110170A/fr not_active Expired
- 1978-05-11 GB GB18871/78A patent/GB1573595A/en not_active Expired
- 1978-05-25 BE BE188049A patent/BE867489A/fr not_active IP Right Cessation
- 1978-05-27 DE DE19782823267 patent/DE2823267A1/de active Granted
- 1978-05-30 FR FR7816125A patent/FR2392669A1/fr active Granted
- 1978-06-01 SE SE7806469A patent/SE434119B/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB1573595A (en) | 1980-08-28 |
DE2823267A1 (de) | 1978-12-14 |
PH13566A (en) | 1980-06-26 |
AU3487778A (en) | 1979-10-11 |
NZ186893A (en) | 1980-04-28 |
US4215130A (en) | 1980-07-29 |
CA1110170A (fr) | 1981-10-06 |
NL189649B (nl) | 1993-01-18 |
BE867489A (fr) | 1978-09-18 |
IE780669L (en) | 1978-11-30 |
IL54505A0 (en) | 1978-07-31 |
ZA781920B (en) | 1979-03-28 |
NL7804523A (nl) | 1978-12-04 |
IE46709B1 (en) | 1983-08-24 |
FR2392669B1 (fr) | 1980-04-11 |
SE7806469L (sv) | 1979-12-02 |
SE434119B (sv) | 1984-07-09 |
AU515368B2 (en) | 1981-04-02 |
NL189649C (nl) | 1993-06-16 |
DE2823267C2 (fr) | 1987-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL930094I2 (nl) | Nieuwe antihistaminen, werkwijze voor de bereidingdaarvan en farmaceutische composities, die deze v erbindingen bevatten. | |
TR199902194T2 (xx) | +p38 protein kinaz inhibit�rleri olarak ikameli azot ihtiva eden heterosikler. | |
ATE38672T1 (de) | 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen. | |
FI882390A0 (fi) | Tetratsolit, jotka ovat verenpainetta alentavien yhdisteiden välituotteita | |
DZ2043A1 (fr) | Nouveaux dérivés. | |
TR200000009T2 (tr) | Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları. | |
TR200101103T2 (tr) | CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar | |
LU90987I2 (fr) | Copaxone et ses dérivés pharmaceutiquement acceptables | |
ES2162843T3 (es) | Inhibidores de la proteina quinasa c. | |
FI840463A0 (fi) | Vissa bensazokinon- och bensazoninonderivat | |
MA20497A1 (fr) | Aryl-(4-5-dihydro-3,5-dioxo-1,2,4-triazine-2(3h)-yle)-benzenteacetonitriles | |
DK229187D0 (da) | 1-substituerede imidazolderivater, 2-thion-tautomere og ikke-toksiske, farmaceutisk acceptable salte deraf | |
ATE290548T1 (de) | Expressionsblockierung von virulenten faktoren in s. aureus | |
DK201590A (da) | Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse | |
FR2392669A1 (fr) | Compositions antihypertensives de clonidine et de phenoxybenzamine | |
FR2392670A1 (fr) | Compositions antihypertensives de lofexidine et de phenoxybenzamines | |
ES2020953B3 (es) | Complejos de tetrahidro-3,4-furanodiamina-n-n'platino. | |
ATE69220T1 (de) | Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen. | |
ES8203842A1 (es) | Procedimiento para la obtencion de 4-aralquil-1,4-dihidro- pirdinas | |
EP0116628A4 (fr) | 1-acyl-3-pyridylmethylguanidines et leur utilisation comme agents anti-hypertensifs. | |
ES2082074T3 (es) | 1,3-difenil-2-propin-1-onas. | |
ATE67992T1 (de) | In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften. | |
DK156490C (da) | Blylegering indeholdende calcium og magnesium | |
FR2666228B1 (fr) | Composition pour le traitement des surcharges ponderales et/ou de la cellulite. | |
DE3152363T1 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |